2025-03-01 · supplements, fat burners, fiber supplements, protein supplements, creatine, green tea extract, berberine, caffeine, apple cider vinegar, safety, yellow-list ingredients, FTC actions
Updated 2026-07-26
Written by Nora Kim
Nora Kim is a WeightFAQ staff writer who translates clinical, surgical, and pharmacological weight-loss research into plain-English guidance. She covers the GLP-1 landscape — semaglutide, tirzepatide, and next-generation drugs — alongside bariatric surgery types, post-op nutrition protocols, and revision options. Her articles also address type 2 diabetes remission, cardiovascular risk, PCOS, fatty liver, night eating syndrome, sarcopenic obesity, and how common medications like antipsychotics, statins, and antidepressants affect weight. Nora writes for readers weighing serious clinical decisions and wanting a clear read on evidence, safety, cost, and realistic outcomes.
18 min read
Medically reviewed on Jul 26, 2026
Weight Loss Supplements Overview
Weight-loss supplements are the biggest gap between what people spend and what the evidence supports. Americans buy roughly $7 billion of them a year. The average rigorous trial finds a pill-only difference of under one kilogram over placebo. A handful of ingredients have real, modest signal (fiber, protein, caffeine, and — through resistance training — creatine). A larger number have weak, mixed, or negative evidence (green-tea extract, berberine, chromium, garcinia, HCA, CLA, apple cider vinegar). A smaller but important group have real, documented harm (synephrine, DMAA/DMBA, ephedra, and the rotating cast of tainted “herbal” products the FDA pulls off the shelf every quarter). This guide separates them by tier, tells you what the best studies actually show, and gives you a short list of the four supplements — and only four — that are worth considering.
Quick stats — weight-loss supplements
- FDA regulation posture: Supplements are regulated under the Dietary Supplement Health and Education Act of 1994 (DSHEA); the FDA does not review them for safety or effectiveness before market.
- Average effect size: Under 1 kg (about 2 lb) over placebo in most meta-analyses of pill-only supplement trials.
- Categories with the strongest signal: Fiber, protein, caffeine, and creatine (as a training adjunct).
- Categories with known harm: Synephrine, DMAA/DMBA, ephedra, unlabeled sibutramine, undeclared prescription drugs in “herbal” blends.
- FTC action count: More than 30 civil enforcement actions against weight-loss supplement makers between 2023 and 2025 for deceptive claims and undisclosed pharmaceutical ingredients.
Key takeaways
- Weight-loss supplements almost never cause meaningful weight loss on their own — the average trial effect is under 1 kg over placebo.
- The FDA does not pre-approve supplements. A product can be on the shelf tomorrow with no proof of safety or effectiveness.
- Only four categories have consistent human evidence for even a modest signal: fiber, protein, caffeine, and creatine (as a training adjunct that protects lean mass).
- Berberine is not “nature’s Ozempic” — it has real glucose effects but no head-to-head data against GLP-1s and important drug interactions.
- Apple cider vinegar’s weight-loss evidence is thin and mostly from a single small industry-funded trial; the real risks (enamel erosion, esophagitis) are better documented than the benefit.
- Actively avoid synephrine, DMAA/DMBA, ephedra, and anything on the FDA’s tainted-products list — those are the ingredients that have hospitalized people.
- If you take any prescription medication, talk to your pharmacist before adding a supplement. Supplement–drug interactions are common and often unlabeled.
Who this is for / not for
Good fit if:
- You are considering a supplement and want an evidence-first read before you spend money.
- You want to compare a supplement’s likely benefit against its cost, safety profile, and drug interactions.
- You are already doing the diet and activity work and want to know whether a supplement adds a small edge or is a waste of money.
- You are on a GLP-1 or other prescription weight-loss medication and want to know which supplements are actually additive vs. redundant vs. risky.
Not a fit if:
- You want a pill that produces GLP-1 magnitude weight loss. It does not exist.
- You are pregnant, breastfeeding, or planning pregnancy — most weight-loss supplements have not been studied in these populations and several are contraindicated.
- You are managing complex cardiovascular, liver, kidney, or thyroid disease — supplement interactions are higher-risk here and merit clinician review before starting anything.
- You are looking for a stimulant to override an unaddressed sleep, mood, or ADHD issue — that is a clinical problem, not a supplement problem.
Why supplements are treated differently than drugs
Prescription and over-the-counter drugs go through the FDA’s Center for Drug Evaluation and Research: they are reviewed for safety, effectiveness, manufacturing quality, and labeling before they can be sold. Weight-loss supplements do not. They are regulated under the Dietary Supplement Health and Education Act of 1994 (DSHEA), which put them in a separate category from drugs and food. Under DSHEA:
- A manufacturer can bring a new supplement to market without submitting effectiveness data to the FDA.
- The FDA can only pull a product off the market after it demonstrates harm — usually after real-world adverse events surface.
- Manufacturers are allowed to make “structure-function” claims (“supports metabolism,” “promotes healthy weight,” “supports fat burning”) without proving them. What they cannot legally do is claim the product treats, cures, or prevents a disease — a distinction many labels quietly ignore.
- “Clinically studied” and “clinically proven” are marketing phrases, not FDA designations. A single small industry-funded trial is enough for the phrase; a null replication rarely is.
- Manufacturing is governed by current Good Manufacturing Practice (cGMP) regulations, but FDA inspection is thin and adulteration is common: independent testing repeatedly finds discrepancies between label and content.
The practical implication is that the burden of proof lives on the consumer. If a product’s ingredients are not on the tier list below, the default assumption should be that it does not work, not that the missing evidence is a coincidence.
The evidence tier framework
The following framework groups every commonly marketed weight-loss ingredient by the strength of the human evidence. Individual products may combine multiple tiers.
- Tier A — may modestly help: Fiber (glucomannan, psyllium, β-glucan), protein (whey, casein), caffeine.
- Tier B — small but real signal: Green tea catechins (EGCG), berberine, creatine (as a training adjunct that supports lean mass during a deficit).
- Tier C — mixed or weak signal: Conjugated linoleic acid (CLA), garcinia cambogia (HCA), chromium picolinate, hydroxycitric acid, L-carnitine.
- Tier D — no meaningful evidence: Raspberry ketones, forskolin, apple cider vinegar (for weight), 7-keto DHEA, most “detox” blends.
- Tier X — known harm, avoid: Synephrine (bitter orange), DMAA, DMBA, ephedra, usnic acid, unlabeled sibutramine, and any product on the FDA’s tainted weight-loss products database.
Treat this list like a triage: if a product’s active ingredient is in Tier D or Tier X, the decision is made. If it is in Tier A or B, the next questions are dose, quality, and interactions.
Category-by-category review
The table below summarizes the ten highest-volume categories. Best-quality trials are cited by first author and year; every one is a real, peer-reviewed publication.
| Category | Typical dose | Evidence tier | Best-quality trial | Notable safety concerns |
|---|---|---|---|---|
| Fiber (glucomannan, psyllium, β-glucan) | 5–15 g/day | A | Keithley 2005 (Alt Ther Health Med); Sood 2008 (Am J Clin Nutr) | GI intolerance, bloating; must be taken with adequate water |
| Protein (whey, casein) | 20–40 g/serving | A | Wycherley 2012 (Am J Clin Nutr) meta-analysis | Safe in normal renal function; watch dairy allergies |
| Caffeine | 200–400 mg/day | A | Astrup 1990 (Am J Clin Nutr); Icken 2016 (Eur J Clin Nutr) | Insomnia, elevated HR and blood pressure, anxiety, tolerance |
| Green tea catechins (EGCG) | 300–500 mg/day | B | Hursel 2009 (Int J Obes) meta-analysis | Rare hepatotoxicity above 800 mg/day of EGCG |
| Berberine | 900–1,500 mg/day | B | Yin 2008 (Metabolism); Lan 2015 (J Ethnopharmacol) | GI upset; CYP3A4 interactions (metformin, statins, cyclosporine) |
| Creatine (recomposition adjunct) | 3–5 g/day | B (for training) | Chilibeck 2017 (Open Access J Sports Med) meta-analysis | Safe; water-weight gain of 1–2 kg in first weeks is normal |
| Apple cider vinegar | 15–30 mL/day | D | Kondo 2009 (Biosci Biotechnol Biochem) — small, industry-funded | Dental enamel erosion, esophagitis, delayed gastric emptying |
| Garcinia cambogia (HCA) | 500–2,800 mg/day | C–D | Onakpoya 2011 (J Obes) review | Hepatotoxicity case reports |
| Chromium picolinate | 200–1,000 mcg/day | C | Onakpoya 2013 (Obes Rev) meta-analysis | Mostly negative for weight; generally well tolerated |
| Probiotics (named strains only — L. gasseri BNR17, B. lactis B420, pasteurized Akkermansia) | 10⁸–10¹⁰ CFU/day | C | Kim 2018 (Nutrients); Stenman 2016 (EBioMedicine); Depommier 2019 (Nat Med) — see probiotics for weight loss | Generally safe in healthy adults; avoid in severe immunocompromise, ICU, central line, or short-bowel/SIBO |
| Synephrine (“bitter orange”) | 20–50 mg/day | X | Cardiovascular case reports (Stohs 2012, review) | Elevated HR and BP; adverse cardiovascular events reported |
The four supplements worth considering (and why)
Only four categories have enough consistent human evidence to earn a spot on a short list. Even these are adjuncts, not drivers.
1. Fiber (glucomannan, psyllium, β-glucan)
Fiber does two useful things at once: it slows gastric emptying (which extends satiety after meals) and it provides bulk that reduces total caloric intake. Glucomannan — the water-soluble fiber from konjac root — has the strongest single-ingredient trial base, showing modest (1–3 kg) weight loss over 8–12 weeks when taken 15–30 minutes before meals with a full glass of water. Psyllium (Metamucil-style) and β-glucan (oat fiber) have similar mechanisms and generally safer GI profiles. The full breakdown of formulation, dose, and timing is covered in our fiber and protein supplements guide.
- Dose: 5–15 g/day, split before meals.
- Timing: 15–30 minutes before a meal, always with a full glass of water — fiber supplements without water have caused esophageal obstruction.
- Cost: $10–25/month for generic psyllium; $20–35/month for glucomannan.
- Quality markers: USP-verified; single-ingredient rather than “cleanse” blends.
2. Protein (whey, casein, or plant blends)
Protein is the highest-satiety macronutrient, and higher-protein weight-loss diets consistently outperform standard-protein diets on both fat-mass loss and lean-mass preservation. The Wycherley 2012 meta-analysis of 24 trials showed roughly 0.8 kg more fat loss and 0.7 kg less lean-mass loss on high-protein energy-restricted diets versus standard-protein energy-restricted diets. A protein powder is not magic — it is just a convenient way to close a protein gap on days you cannot get 1.6–2.2 g/kg from food.
- Dose: 20–40 g per serving, up to 1.6–2.2 g/kg body weight total per day when in a deficit.
- Timing: Anytime; post-workout is convenient but not required for weight loss.
- Cost: $25–60 for a month’s supply of quality whey; plant blends slightly more.
- Quality markers: NSF-Certified for Sport, Informed-Sport, or third-party tested for heavy metals.
3. Caffeine
Caffeine reliably increases resting energy expenditure by 3–4% and modestly reduces short-term appetite. In observational data, higher habitual caffeine intake tracks with better long-term weight-loss maintenance (Icken 2016). The catch is that tolerance develops within weeks, and the marginal benefit of pushing past 400 mg/day is outweighed by insomnia, elevated blood pressure, and dependence. Coffee (2–4 cups spread through the morning) delivers the same 200–400 mg with fiber, water, and polyphenols attached. For a deeper look at the coffee-versus-capsule tradeoff, see our coffee and caffeine for weight loss guide.
- Dose: 200–400 mg/day; avoid stacking with pre-workouts and fat burners that also contain it.
- Timing: Before noon; late-day caffeine measurably damages sleep quality even in people who feel fine falling asleep.
- Cost: Coffee is essentially free; caffeine tablets are $5–10/month.
- Quality markers: Prefer coffee or plain caffeine tablets over “thermogenic” blends.
4. Creatine (as a training adjunct)
Creatine is not a fat-burner. It is a training aid that helps preserve or build lean mass during a caloric deficit. Chilibeck 2017’s meta-analysis in Open Access Journal of Sports Medicine showed roughly 1.4 kg more lean-mass gain with creatine + resistance training vs. resistance training alone. In a weight-loss context that matters, because losing weight without preserving muscle lowers resting metabolic rate and worsens body composition. The full case for creatine during a deficit is in our creatine and weight loss piece.
- Dose: 3–5 g/day of creatine monohydrate; no loading phase needed.
- Timing: Anytime; consistency matters more than timing.
- Cost: $8–15/month for third-party tested monohydrate.
- Quality markers: Creapure or an NSF-Certified for Sport monohydrate; skip proprietary “advanced” creatine variants.
The berberine and “nature’s Ozempic” story
Berberine deserves an honest, separate section because the marketing has outrun the science. Berberine is a plant alkaloid extracted from Berberis species (barberry, Oregon grape, goldenseal). It has real biological effects:
- Glucose: Yin 2008 in Metabolism found HbA1c reductions comparable to metformin at 1.5 g/day of berberine in type 2 diabetes over three months. Lan 2015 in the Journal of Ethnopharmacology pooled 27 randomized controlled trials and confirmed meaningful reductions in fasting glucose and HbA1c.
- Lipids: The same meta-analytic literature shows meaningful reductions in total cholesterol, LDL-C, and triglycerides.
- Weight: The weight signal is real but small — usually 2–5 lb over three months, not the 15–20% seen with GLP-1s.
Where the “nature’s Ozempic” framing fails:
- No head-to-head trials against semaglutide or tirzepatide exist. The comparison is marketing extrapolation.
- Mechanism is not GLP-1 agonism. Berberine activates AMPK, not the GLP-1 receptor; the appetite-suppression profile that makes GLP-1s so effective is not part of berberine’s pharmacology.
- Drug-interaction risk is significant. Berberine is a potent inhibitor of CYP3A4, one of the main hepatic drug-metabolizing enzymes. It can raise blood levels of statins, cyclosporine, tacrolimus, some benzodiazepines, and many others — a real problem if you are on any of these.
- Additive with metformin is questionable. Stacking berberine on top of metformin does not consistently improve glycemic control and can increase GI side effects.
Berberine is a reasonable option for a patient with prediabetes or dyslipidemia who cannot tolerate metformin and whose clinician has cleared the drug-interaction list. It is not a substitute for a GLP-1 in obesity treatment. For a deeper look at the meta-analytic weight-loss numbers, PCOS-specific evidence, dosing, and the hepatotoxicity signal, see berberine for weight loss.
Supplements to actively avoid
- Synephrine (bitter orange, Citrus aurantium): The most common ephedra replacement. Elevated heart rate and blood pressure; cardiovascular events documented in case reports.
- DMAA (1,3-dimethylamylamine) and DMBA (1,3-dimethylbutylamine): Amphetamine-like stimulants; banned by the FDA in supplements but still turn up in “pre-workouts” and fat burners.
- Ephedra (Ephedra sinica, ma huang): Banned in the U.S. in 2004 after cardiovascular deaths, but occasionally reappears in imported products.
- Usnic acid: Marketed for weight loss; withdrawn from major brands after severe liver injury.
- Anything on the FDA tainted weight-loss products database: A rolling list of over 1,000 supplements found by FDA laboratories to contain undeclared prescription pharmaceuticals such as sibutramine (withdrawn for cardiovascular events), phenolphthalein (suspected carcinogen), fluoxetine, and diuretics. The tainted-products list is the single most useful safety cross-reference before buying any weight-loss supplement — especially anything imported or purchased from a marketplace rather than a pharmacy. For the broader landscape of what makes weight-loss products safe or unsafe, see our weight-loss drug safety guide.
- “Detox,” “cleanse,” and “flush” blends: Weight change from these is water loss and laxative-induced GI transit; the mechanism is dehydration, not fat loss, and the harm is electrolyte disturbance.
If a monthly $40–$80 supplement stack is not moving the scale, the same budget usually goes further inside a structured behavioral program with a food-logging habit and coach accountability — our Noom weight loss program guide walks through the honest evidence and price for one popular option in that category, and the behavioral therapy for weight loss guide covers cheaper CBT-based alternatives.
Interactions with weight-loss medications
Supplement–drug interactions are common, under-labeled, and often overlooked in visits. The table below shows the highest-yield combinations to raise with a clinician or pharmacist.
| Supplement | Prescription medication | Interaction concern |
|---|---|---|
| Caffeine (any source) | Phentermine, bupropion, other stimulants | Additive tachycardia, elevated BP, anxiety, insomnia |
| Berberine | Metformin | Additive GI upset; questionable additive glycemic benefit |
| Berberine | Statins, cyclosporine, tacrolimus, some benzodiazepines | CYP3A4 inhibition raises drug levels |
| Fiber (any) | Levothyroxine, oral contraceptives, metformin, GLP-1s | Absorption interference — separate by ≥ 2 hours |
| Green tea extract | Statins, methotrexate, warfarin | Hepatic-clearance competition; potential bleeding risk |
| Green tea extract (high dose) | Any hepatically cleared drug | Hepatotoxicity risk above 800 mg/day EGCG |
| Synephrine | MAO inhibitors, stimulants, phentermine | Serious cardiovascular risk — avoid |
| Chromium | Insulin, sulfonylureas | Additive hypoglycemia (small effect) |
| St. John’s wort (often bundled in “mood + weight” blends) | Oral contraceptives, warfarin, SSRIs, many others | Potent CYP3A4 induction — reduces drug efficacy |
If you are on a GLP-1, phentermine, or naltrexone-bupropion combination, review supplements with your prescriber before starting. The same is true for anyone on an anticoagulant, thyroid replacement, an SSRI, or a transplant medication.
What “third-party tested” actually means
Third-party testing is a partial fix for the fact that supplement manufacturing quality is uneven. The four programs consumers see most often:
- USP Verified (United States Pharmacopeia): The most rigorous of the widely used marks. Verifies identity, potency, purity (heavy metals, pesticides, microbial), and cGMP compliance. The USP mark is one of the strongest quality signals available in the supplement aisle.
- NSF Certified / NSF Certified for Sport: Similar to USP; adds screening for over 280 substances banned by major sports organizations. Widely used by athletes because a certified product will not trigger a doping violation.
- ConsumerLab.com: A subscription lab that independently tests and reports on products. Not a certification you look for on the label — you read their reports before buying.
- Informed-Sport / Informed-Choice: Batch-tested for banned substances, similar in scope to NSF Certified for Sport.
A product with no third-party mark is not necessarily bad, but the burden of trust is higher. For products with a track record of adulteration — fat burners, “test boosters,” pre-workouts — insist on one of these marks.
Red flags in supplement marketing
Any single one of these should slow you down. Two or more, put the bottle back on the shelf.
- “Proprietary blend.” The label lists a total milligram number and the ingredients, but not the dose of each. Almost always used to hide underdosed active ingredients and overdosed cheap fillers.
- “As seen on TV” or celebrity endorsements. Neither is evidence.
- “Doctor-formulated” or “clinically proven” without a linked, publicly available trial. A named clinician is not a citation.
- Before-and-after photos in advertising. Federal law technically prohibits deceptive testimonials; enforcement is inconsistent.
- Rapid, dramatic weight-loss promises (“lose 30 lb in 30 days,” “melt belly fat overnight”). Not physiologically possible from a supplement.
- Marketplace-only availability (Amazon third-party sellers, eBay, TikTok Shop) with no clinical, pharmacy, or health-store presence. Higher rates of adulteration and counterfeiting.
When to talk to your clinician first
Do not start a weight-loss supplement without a clinician conversation if any of the following apply:
- You are pregnant, breastfeeding, or planning pregnancy.
- You have cardiovascular disease, uncontrolled hypertension, or a history of arrhythmia.
- You have kidney or liver disease.
- You are on a GLP-1 (semaglutide, tirzepatide, liraglutide) or any other prescription weight-loss medication.
- You have thyroid disease or take levothyroxine.
- You are on an anticoagulant (warfarin, apixaban, rivaroxaban).
- You are on a transplant medication (cyclosporine, tacrolimus).
- You are under 18.
Bring the actual bottle to the visit and read the ingredient panel out loud. Your pharmacist is often a better resource for interaction screening than the busy primary-care visit — this is exactly the workflow retail-pharmacy consultations are built for.
Sources at a glance
- Keithley J, Swanson B. Glucomannan and obesity: a critical review. Alternative Therapies in Health and Medicine 2005.
- Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. American Journal of Clinical Nutrition 2008.
- Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 2012.
- Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. American Journal of Clinical Nutrition 1990.
- Icken D, Feller S, Engeli S, et al. Caffeine intake is related to successful weight loss maintenance. European Journal of Clinical Nutrition 2016.
- Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. International Journal of Obesity 2009.
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008.
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipidemia, and hypertension. Journal of Ethnopharmacology 2015.
- Chilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access Journal of Sports Medicine 2017.
- Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Bioscience, Biotechnology, and Biochemistry 2009.
- Onakpoya IJ, Hung SK, Perry R, Wider B, Ernst E. The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Journal of Obesity 2011.
- Onakpoya IJ, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obesity Reviews 2013.
- U.S. Food and Drug Administration. Tainted weight-loss products database. Ongoing.
- U.S. Federal Trade Commission. Enforcement actions against weight-loss supplement makers, 2023–2025.
Related on WeightFAQ
- Fat-burner supplements — category-by-category review of thermogenic products.
- Appetite-suppressant supplements — glucomannan, 5-HTP, and OTC hunger-control options.
- Fiber and protein supplements — formulation, timing, and quality markers for the two Tier-A categories.
- Coffee and caffeine for weight loss — dose, tolerance, and coffee-vs-capsule tradeoffs.
- Apple cider vinegar for weight loss — the honest read on the vinegar evidence and its downsides.
- Weight-loss drug safety — how to evaluate any weight-loss product for safety and adulteration risk.
Sources
- Keithley J, Swanson B. Glucomannan and obesity: a critical review. Alternative Therapies in Health and Medicine (2005).
- Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. The American Journal of Clinical Nutrition (2008).
- Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition (2012).
- Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects. The American Journal of Clinical Nutrition (1990).
- Icken D, Feller S, Engeli S, et al. Caffeine intake is related to successful weight loss maintenance. European Journal of Clinical Nutrition (2016).
- Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. International Journal of Obesity (2009).
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism (2008).
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipidemia, and hypertension. Journal of Ethnopharmacology (2015).
- Chilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Open Access Journal of Sports Medicine (2017).
- Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat mass, and serum triglyceride levels in obese Japanese subjects. Bioscience, Biotechnology, and Biochemistry (2009).
- Onakpoya IJ, Hung SK, Perry R, Wider B, Ernst E. The use of Garcinia extract (hydroxycitric acid) as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Journal of Obesity (2011).
- Onakpoya IJ, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obesity Reviews (2013).
- U.S. Food and Drug Administration. Tainted weight-loss products database.